Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

903
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
903

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanical and Strain-Sensing Responses in Functional ZnO Tetrapod - Silk Fibroin Composites: A Detailed Investigation of the Roles of Filler Size and Shape.

ACS omega·2026
Same author

TENG-Driven Electrotherapy: A Self-Powered Approach to Inducing Cancer Cell Apoptosis.

ACS applied bio materials·2026
Same author

Eco-friendly synthesis of ZnO nanostructures from yeast strains isolated from kombucha and beetroot kwass for antimicrobial thin film applications.

Bioprocess and biosystems engineering·2026
Same author

Characterizing Multifunctional Mesoporous Cerium Silicate Nanoparticles for Potential Use in Bioactive Dental Materials: A Proof-of-Concept Study.

Materials (Basel, Switzerland)·2026
Same author

Interfacial V<sup>5+</sup>/V<sup>4+</sup> Redox Kinetics Enabling Fe-free Photo-Fenton Catalysis in α-V<sub>2</sub>O<sub>5</sub>-ACNT Nanohybrids for Efficient Removal of Mixed CBZ and DFN.

ACS applied materials & interfaces·2026
Same author

Biosensing of Steroid Hormones with 3D Zinc Oxide Tetrapods.

ACS omega·2026

Related Experiment Video

Updated: Jul 27, 2025

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

23.4K

Lipid nanoparticle-based formulations for high-performance dentistry applications.

Isha Mutreja1, Dhiraj Kumar2, Ajeet Kaushik3

  • 1Minnesota Dental Research Center for Biomaterials and Biomechanics, Department of Restorative Sciences, University of Minnesota, Moos Health Science Tower, 515 Delaware Street S.E., Minneapolis, MN 55455, USA. imutreja@umn.edu.

Journal of Materials Chemistry. B
|June 6, 2023
PubMed
Summary

Nanolipids show promise as affordable, biologically acceptable antibacterial nanostructures for dental care. This review bridges the knowledge gap for their clinical translation and FDA approval in dentistry.

More Related Videos

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

17.9K

Related Experiment Videos

Last Updated: Jul 27, 2025

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

23.4K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

9.0K
Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications
08:19

Solid Lipid Nanoparticles SLNs for Intracellular Targeting Applications

Published on: November 17, 2015

17.9K

Area of Science:

  • Biomaterials science
  • Nanotechnology
  • Dental research

Background:

  • Growing need for novel, high-performance, and affordable biomaterials in dentistry to combat oral diseases.
  • Challenges with existing dental materials include cytotoxicity and limited clinical acceptance.
  • Nanolipids offer a promising avenue for next-generation dental therapeutics.

Purpose of the Study:

  • To address the knowledge gap in developing and translating nanolipid formulations for dental applications.
  • To critically review literature for selecting appropriate nanolipid systems for targeted dental issues.
  • To discuss the future of nanolipids in dentistry, focusing on clinical adaptability, risks, and regulatory pathways.

Main Methods:

  • Comprehensive literature review and critical analysis of existing research on nanolipids in dentistry.
  • Evaluation of nanolipid properties, formulation strategies, and pharmacological potential.
  • Exploration of challenges and alternative approaches for clinical translation and FDA approval.

Main Results:

  • Nanolipids can be designed as programmable systems with tunable responsiveness for targeted disease management.
  • Identification of key considerations for selecting nanolipid systems based on specific dental conditions.
  • Summary of the current state of research, highlighting areas needing further investigation.

Conclusions:

  • Nanolipids represent a significant advancement for developing advanced dental care solutions.
  • Systematic research and addressing potential risks are crucial for successful clinical translation and FDA approval.
  • Further studies focusing on clinical adaptability will pave the way for nanolipid integration into routine dental practice.